Covid-19 roundup: As­traZeneca strug­gling to com­pile da­ta for FDA OK — re­port

Over a month af­ter an­nounc­ing Phase III da­ta for the Covid-19 shot, As­traZeneca still has not filed an FDA OK. And it could be an­oth­er few weeks be­fore the Big Phar­ma does.

As­traZeneca ex­ec­u­tives re­cent­ly told the FDA they might need un­til mid-May to ap­ply for an emer­gency use au­tho­riza­tion, the Wall Street Jour­nal re­port­ed. When they had an­nounced the da­ta in March, the com­pa­ny said they would file by mid-April.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER